Weight Loss Supplement Market size is set to grow by USD 1.53 billion from 2024-2028, Growing obese population to boost the market growth, Technavio
NEW YORK, July 1, 2024 /PRNewswire/ -- The global weight loss supplement market size is estimated to grow by USD 1.53 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 4.96% during the forecast period.
For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2018 - 2022) - Download a Sample Report
The growth of the weight loss supplement market is being driven by a number of factors, including:
Increasing awareness of health and wellness
Rising prevalence of obesity and related health issues
Growing demand for effective and safe weight loss solutions
Use of innovative technologies and research and development in creating new and improved weight loss supplements
The market is segmented based on product type, distribution channel, and geography. The competitive landscape is characterized by a high level of competition, with businesses focusing on product innovation, pricing strategies, and marketing efforts to differentiate themselves from competitors.
Some of the challenges facing the weight loss supplement market include:
Stringent regulations
Limited responsible marketing
Difficulty for consumers to stick to diets and exercise routines
Debate over the effectiveness and safety of some weight loss supplements
The weight loss supplement market is expected to continue to grow in the coming years, driven by the increasing demand for weight loss solutions and the expanding consumer base.
Learn and explore more about Technavio's in-depth research reports
The paracetamol market continues to expand globally, driven by its widespread use as a pain reliever and fever reducer. Increasing consumer awareness about its safety and effectiveness further boosts demand. In contrast, the antibiotics market faces challenges amid growing concerns over antibiotic resistance. Despite this, strategic innovations in drug development and stringent regulatory measures aim to sustain market growth. As a Senior Research Analyst with extensive experience, navigating these dynamics involves conducting in-depth market research, competitive analysis, and strategic advisory to optimize market positioning and capitalize on emerging opportunities.
Regulatory News:
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced artificial intelligence (AI) to accelerate biopharma drug discovery, today announces a change to its Executive Leadership Team...
In the news release, AbbVie, Inc.'s Zymaxid tm Implicated in Product Liability Lawsuit Due to Risk of Serious Injury and Death, issued 02-Jul-2024 by Wormington & Bollinger over PRWeb, the source of the release should be "Wormington & Bollinger"...
Author David W. Treaster shares a Christian-based plan that can supplement a cancer patient's medical treatment plan in God Power Cancer Healing Plan: Spiritual Component ($15.99, paperback, 9781662899942; $7.99, e-book, 9781662899959).
As long as...
In a groundbreaking medical feat, LiverIndia's Dr Karthik Mathivanan, a renowned Liver Transplant surgeon in Chennai with over 15 years of experience in multi-organ transplant surgery, has successfully utilised the emerging field of transplant...
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for 225Ac-FL-020, the company's lead radiopharmaceutical,...
Vitality Products Inc. (the "Company" or "Vitality"), a manufacturer, marketer and distributor of premium vitamins and supplements, is pleased to report its financial results for the first quarter ended April 30, 2024 and provide a business update....